IL9 and neoplasm: The interference of IL-9 signaling by either IL-9 neutralizing antibody or depleting Treg cells weakened BMMCs-mediated MDSC infiltration toward tumor (Fig. 6C), and attenuated BMMCs-enhanced tumor growth (Fig. 6D).